1 / 20

E fficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL)

E fficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) inJapanese women aged 18–26 years Hiroyuki Yoshikawa,1 Keiko Ebihara,2 Yoshiyuki Tanaka2,4 and Kiichiro Noda3. Participants and Methods. Results. Discussion. Good luck!.

nolcha
Télécharger la présentation

E fficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Efficacy of quadrivalenthuman papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) inJapanesewomen aged 18–26 years Hiroyuki Yoshikawa,1 Keiko Ebihara,2 Yoshiyuki Tanaka2,4 and Kiichiro Noda3

  2. Participants and Methods

  3. Results

  4. Discussion

  5. Good luck!

More Related